CClinicalTrials.gg
CompletedNCT06061289Updated Sep 29, 2023

Guided Metabolic Detox Program

An interventional study of SP Detox Program in Detoxification Response, sponsored by Standard Process Inc.. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-09-29.

Sponsored by Standard Process Inc. · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Mar 2022, registered Mar 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Adequate antioxidant supply is essential for maintaining metabolic homeostasis and reducing oxidative stress during detoxification. The emerging evidence suggests that certain classes of phytonutrients can help support the detoxification process by stimulating the liver to produce detoxification enzymes or acting as antioxidants that neutralize the harmful effects of free radicals. This study was designed to examine the effects of a guided 28-day metabolic detoxification program in healthy adults. The participants were randomly assigned to consume a whole food, multi-ingredient supplement (education and intervention) or control (education and healthy meal) daily for the duration of the trial.

Read the detailed description

In this study, the focus is on a cohort of healthy adults enrolled in a guided detoxification program that included a healthy diet education session with or without 28-day nutritional supplementation with a whole food, proprietary multicomponent blend. The primary objective was to determine the improvement in quality of life by a validated self-reported wellness questionnaire known as Promis Global 10. The secondary outcomes were to quantify the functional markers of metabolic detoxification in blood and urine compared to the study baseline to understand the efficacy of the study formulation as part of 28-day nutritional supplementation with a whole food, proprietary multicomponent blend.

02

Conditions studied

  • Detoxification Response

Keywords

  • Detoxification
  • Whole Food Vitamins
  • Glutathione
  • liver
  • antioxidants
  • SOD
  • GST
03

In context

Lead sponsor

Standard Process Inc. is the lead sponsor of 11 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Willingness to comply with study protocol for 30 days
  • No allergy to any study products (check formulation section below)
  • Participant is over 18 years of age or older
  • Participant is a male or a non-pregnant, non-lactating female, at least 6 weeks postpartum prior to screening visit, and is not actively planning a pregnancy.
  • Participant has at least two weeks wash out period between completion of a previous research study that required ingestion of any study food or drug and their start in the current study.

Exclusion criteria

Exclusion Criteria:

  • Prohibited Medications, Supplements or Herbal Products

    • Subjects who are experiencing any adverse events due to any nutraceutical, OTC, or pharmaceutical or investigational products
    • Celiac and other gastrointestinal health concerns
    • Subjects may not receive any other investigational products not part of normal clinical care
    • Lipid lowering drugs or the use of anticoagulant medications in the preceding 4 weeks and for duration of study
  • Pregnant and nursing women are excluded from participation and women of childbearing age expecting to be pregnant soon will be excluded from the study
  • TC levels less than 220
  • Subjects with untreated endocrine, neurological, or infectious disease
  • Subjects with the diagnosis of HIV disease or AIDS
  • Significant liver or kidney disease (recent or ongoing hepatitis, cirrhosis, glomerulonephritis, dialysis treatment)
  • Rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus, polymyositis, scleroderma, polymyalgia rheumatic, temporal arteritis or Reiter's Syndrome
  • Psoriasis, Deep vein thrombosis or pulmonary embolus (blood clot to lungs)
  • History of cancer
  • Serious medical illness
  • Substance Use - Use of ethanol within 24 hours of the evaluation visits (baseline, 4 weeks)
  • Any other sound medical, psychiatric and/or social reason as determined by the PI
  • Co-enrollment in other studies is restricted. Study staff should be notified of co-enrollment as it may require the approval of the investigator
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
32 participants (actual)

Study arms

  • No intervention
    Education and healthy diet

    The healthy diet education session included a PowerPoint presentation on healthy dietary guidelines and sample recipes of healthy meals.

  • Experimental
    Detox

    The guided component of the detoxification program included an additional PowerPoint presentation with the information about the investigational product, directions, and dosing information for its consumption.

    Dietary Supplement: SP Detox Program

Interventions

  • Dietary supplementSP Detox Program

    The production use and disposal of toxic chemicals and synthetic materials have increased the risk of exposure to health-threatening toxins. Causal relationships between toxic chemicals and diseases have been well established. However, many patients endure chronic symptoms that are associated with exposure to toxins before advanced stages of specific diseases are realized. Thus, there is a great demand for noninvasive laboratory tests that can provide timely assessment of chemical exposure and the capability of hepatic detoxification

06

What researchers measure

Primary outcomes

  1. Promis Global 10 (Self- reported Wellness) Questionnaire

    The PROMIS Global short form was scored into a Global Physical Health component and Global Mental Health component. The summed raw scores from PROMIS Global were converted into standardized T-score distributions such that a 50 represents the average (mean) for the US general population. A high score always represents more of the concept being measured.

    Time frame: 28 days

Secondary outcomes

  1. Total Serum Antioxidants

    Total Antioxidant Capacity ( μM ) measured as the combined antioxidant activities of all serum constituents, including vitamins, proteins, lipids, glutathione, and uric acid. This assay will be performed using a commercial kit following manufacturer's instruction.

    Time frame: 28 days

  2. Oxidative Stress

    Colorimetric method to study redox status of peripheral blood mononuclear cells (PBMCs) in Relative fluorescence units (RFU)

    Time frame: 28 days

  3. Detoxification Enzyme Activity - SOD

    Assessment of SOD activity (units/mL) using an assay that utilizes a tetrazolium salt for detection of superoxide radicals generated by xanthine oxidase and hypoxanthine using a colorimetric method.

    Time frame: 28 days

  4. Detoxification Enzyme Activity - GST

    Total GST activity (units/mL) measured by quantifying the conjugation of 1-chloro-2,4-dinitrobenzene (CDNB) with reduced glutathione using a glutathione S-transferase assay kit

    Time frame: 28 days

  5. Urinary Detox marker

    Excreted Porphyrins concentration in urine (nmol/mg)

    Time frame: 28 days

  6. Hepatic detox marker -1

    Excreted D-glucaric acid concentration in urine ((nM/mg)

    Time frame: 28 days

  7. Hepatic detox marker -2

    Excreted Mercapturic acid concentration in urine ((μM/mM)

    Time frame: 28 days

  8. Total Glutathione

    Serum concentration of Glutathione (uM) was measured as part of a fluorometric assay.

    Time frame: 28 days

07

Study locations

1 site
  • De-Rusha Clinic, Northwestern Health Sciences University
    Bloomington, Minnesota 55431, United States
08

References and documents

Publications

  • Sears ME, Genuis SJ. Environmental determinants of chronic disease and medical approaches: recognition, avoidance, supportive therapy, and detoxification. J Environ Public Health. 2012;2012:356798. doi: 10.1155/2012/356798. Epub 2012 Jan 19. PubMed 22315626 ↗
  • Bonakdar RA, Sweeney M, Dalhoumi S, Adair V, Garvey C, Hodge T, Herrala L, Barbee A, Case C, Kearney J, Smith K, Hwang J. Detoxification Enhanced Lifestyle Intervention Targeting Endotoxemia (DELITE) in the Setting of Obesity and Pain: Results of a Pilot Group Intervention. Integr Med (Encinitas). 2020 Oct;19(5):16-28. PubMed 33488302 ↗
  • Mostafalou S, Abdollahi M. Pesticides and human chronic diseases: evidences, mechanisms, and perspectives. Toxicol Appl Pharmacol. 2013 Apr 15;268(2):157-77. doi: 10.1016/j.taap.2013.01.025. Epub 2013 Feb 9. PubMed 23402800 ↗
  • Jochmanova I, Lazurova Z, Rudnay M, Bacova I, Marekova M, Lazurova I. Environmental estrogen bisphenol A and autoimmunity. Lupus. 2015 Apr;24(4-5):392-9. doi: 10.1177/0961203314560205. PubMed 25801882 ↗
  • Liska D, Lyon M, Jones DS. Detoxification and biotransformational imbalances. Explore (NY). 2006 Mar;2(2):122-40. doi: 10.1016/j.explore.2005.12.009. No abstract available. PubMed 16781626 ↗
  • Polanska K, Jurewicz J, Hanke W. Review of current evidence on the impact of pesticides, polychlorinated biphenyls and selected metals on attention deficit / hyperactivity disorder in children. Int J Occup Med Environ Health. 2013 Mar;26(1):16-38. doi: 10.2478/s13382-013-0073-7. Epub 2013 Mar 22. PubMed 23526196 ↗
  • Hodges RE, Minich DM. Modulation of Metabolic Detoxification Pathways Using Foods and Food-Derived Components: A Scientific Review with Clinical Application. J Nutr Metab. 2015;2015:760689. doi: 10.1155/2015/760689. Epub 2015 Jun 16. PubMed 26167297 ↗
  • Proudfoot AT, Krenzelok EP, Vale JA. Position Paper on urine alkalinization. J Toxicol Clin Toxicol. 2004;42(1):1-26. doi: 10.1081/clt-120028740. PubMed 15083932 ↗
  • Berardi JM, Logan AC, Rao AV. Plant based dietary supplement increases urinary pH. J Int Soc Sports Nutr. 2008 Nov 6;5:20. doi: 10.1186/1550-2783-5-20. PubMed 18990209 ↗
  • Konig D, Muser K, Dickhuth HH, Berg A, Deibert P. Effect of a supplement rich in alkaline minerals on acid-base balance in humans. Nutr J. 2009 Jun 10;8:23. doi: 10.1186/1475-2891-8-23. PubMed 19515242 ↗
  • Minich DM, Bland JS. Acid-alkaline balance: role in chronic disease and detoxification. Altern Ther Health Med. 2007 Jul-Aug;13(4):62-5. PubMed 17658124 ↗
  • Griendling KK, Touyz RM, Zweier JL, Dikalov S, Chilian W, Chen YR, Harrison DG, Bhatnagar A; American Heart Association Council on Basic Cardiovascular Sciences. Measurement of Reactive Oxygen Species, Reactive Nitrogen Species, and Redox-Dependent Signaling in the Cardiovascular System: A Scientific Statement From the American Heart Association. Circ Res. 2016 Aug 19;119(5):e39-75. doi: 10.1161/RES.0000000000000110. Epub 2016 Jul 14. PubMed 27418630 ↗
  • Zweier JL, Duke SS, Kuppusamy P, Sylvester JT, Gabrielson EW. Electron paramagnetic resonance evidence that cellular oxygen toxicity is caused by the generation of superoxide and hydroxyl free radicals. FEBS Lett. 1989 Jul 31;252(1-2):12-6. doi: 10.1016/0014-5793(89)80881-6. PubMed 2547649 ↗
  • Pastore A, Federici G, Bertini E, Piemonte F. Analysis of glutathione: implication in redox and detoxification. Clin Chim Acta. 2003 Jul 1;333(1):19-39. doi: 10.1016/s0009-8981(03)00200-6. PubMed 12809732 ↗
  • Lee DH, Blomhoff R, Jacobs DR Jr. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res. 2004 Jun;38(6):535-9. doi: 10.1080/10715760410001694026. PubMed 15346644 ↗
  • Chen CA, Wang TY, Varadharaj S, Reyes LA, Hemann C, Talukder MA, Chen YR, Druhan LJ, Zweier JL. S-glutathionylation uncouples eNOS and regulates its cellular and vascular function. Nature. 2010 Dec 23;468(7327):1115-8. doi: 10.1038/nature09599. PubMed 21179168 ↗
  • Varadharaj S, Kelly OJ, Khayat RN, Kumar PS, Ahmed N, Zweier JL. Role of Dietary Antioxidants in the Preservation of Vascular Function and the Modulation of Health and Disease. Front Cardiovasc Med. 2017 Nov 1;4:64. doi: 10.3389/fcvm.2017.00064. eCollection 2017. PubMed 29164133 ↗
  • Yen CH, Tseng YH, Kuo YW, Lee MC, Chen HL. Long-term supplementation of isomalto-oligosaccharides improved colonic microflora profile, bowel function, and blood cholesterol levels in constipated elderly people--a placebo-controlled, diet-controlled trial. Nutrition. 2011 Apr;27(4):445-50. doi: 10.1016/j.nut.2010.05.012. Epub 2010 Jul 10. PubMed 20624673 ↗
  • Chen HL, Lu YH, Lin JJ, Ko LY. Effects of isomalto-oligosaccharides on bowel functions and indicators of nutritional status in constipated elderly men. J Am Coll Nutr. 2001 Feb;20(1):44-9. doi: 10.1080/07315724.2001.10719013. PubMed 11294172 ↗
  • Zhao ZY, Liang L, Fan X, Yu Z, Hotchkiss AT, Wilk BJ, Eliaz I. The role of modified citrus pectin as an effective chelator of lead in children hospitalized with toxic lead levels. Altern Ther Health Med. 2008 Jul-Aug;14(4):34-8. Erratum In: Altern Ther Health Med. 2008 Nov-Dec;14(6):18. PubMed 18616067 ↗
  • Zhang N, Huang C, Ou S. In vitro binding capacities of three dietary fibers and their mixture for four toxic elements, cholesterol, and bile acid. J Hazard Mater. 2011 Feb 15;186(1):236-9. doi: 10.1016/j.jhazmat.2010.10.120. Epub 2010 Nov 9. PubMed 21095057 ↗
  • Eliaz I, Hotchkiss AT, Fishman ML, Rode D. The effect of modified citrus pectin on urinary excretion of toxic elements. Phytother Res. 2006 Oct;20(10):859-64. doi: 10.1002/ptr.1953. PubMed 16835878 ↗
  • Cuervo A, Salazar N, Ruas-Madiedo P, Gueimonde M, Gonzalez S. Fiber from a regular diet is directly associated with fecal short-chain fatty acid concentrations in the elderly. Nutr Res. 2013 Oct;33(10):811-6. doi: 10.1016/j.nutres.2013.05.016. Epub 2013 Jul 26. PubMed 24074739 ↗
  • Cline JC. Nutritional aspects of detoxification in clinical practice. Altern Ther Health Med. 2015 May-Jun;21(3):54-62. PubMed 26026145 ↗

Related links

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 29, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06061289
Lead sponsor
Standard Process Inc.
Collaborators
Northwestern Health Sciences University
Responsible party
Sponsor
First posted
Sep 29, 2023
Start date
Mar 6, 2022
Primary completion
Aug 27, 2022
Completion
Sep 30, 2022
Last update
Sep 29, 2023

Study contacts

Chinmayee Panda, PhD
principal investigator · Standard Process Inc.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion